Your browser doesn't support javascript.
loading
Correction to: Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial.
Zhang, Wenhui; Scalori, Astrid; Fuh, Franklin; McBride, Jacqueline; She, Gaohong; Kierkus, Jaroslaw; Korczowski, Bartosz; Li, Regan; Abouhossein, Mariam; Kadva, Alysha; Park, K T; Tang, Meina Tao.
Afiliação
  • Zhang W; Genentech, Inc., South San Francisco, CA, USA.
  • Scalori A; Roche Products Limited, Welwyn Garden City, United Kingdom.
  • Fuh F; Genentech, Inc., South San Francisco, CA, USA.
  • McBride J; Genentech, Inc., South San Francisco, CA, USA.
  • She G; Genentech, Inc., South San Francisco, CA, USA.
  • Kierkus J; Children's Memorial Health Institute, Warsaw, Poland.
  • Korczowski B; University of Rzeszów, Rzeszów, Poland.
  • Li R; Roche Products Limited, Welwyn Garden City, United Kingdom.
  • Abouhossein M; Genentech, Inc., South San Francisco, CA, USA.
  • Kadva A; Genentech, Inc., South San Francisco, CA, USA.
  • Park KT; Genentech, Inc., South San Francisco, CA, USA.
  • Tang MT; Genentech, Inc., South San Francisco, CA, USA.
Inflamm Bowel Dis ; 28(10): e143, 2022 Oct 03.
Article em En | MEDLINE | ID: mdl-35366308

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article